Rajasthan PPP Revenue Run-rate
Expect ₹300-350 crore annualized revenue from Rajasthan PPP project with ₹200-250 crore capex investment, reaching full potential in 1.5-2 years from FY27 onwards.
KRSNAA / guidance tracker
Keep management guidance in view.
Krsnaa Diagnostics · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
revenue
Retail Revenue Contribution
Targeting 5-8% retail contribution to total revenue by FY26, scaling to 18-20% over the next two years with B2C focus.
Retail EBITDA Break-even
Retail venture (RPL) expected to achieve EBITDA break-even by end of FY26 as business matures and scales with PPP infrastructure leverage.
Maharashtra Radiology Completion
Major portion (~75%) of Maharashtra CT and MRI rollout (73 centers) to be completed by Q3 FY26 end, with remaining sites by Q4.
Rajasthan Revenue: ₹100-150 crore annually
Conservative guidance for Rajasthan PPP project as first-year ramp-up; management acknowledges upside potential as collection centers and labs get fully activated in Q1-Q2 FY27.
DSO Target: Sub-120 days by FY27
Collections improvement journey on track; reduced from 155 days (Q3) to 139 days (Q4) through stronger documentation and government engagement.
Retail contribution to double digits in FY27
Retail business scaling rapidly (₹10 crore to ₹60 crore in one year); expected to exceed 10% of revenue in FY27 with 3,500+ touchpoints and 500+ franchise centers.
FY27 Capex: ₹500 crore
Capital investment planned for Rajasthan (~₹300 crore), MRI projects (~₹150 crore), and smaller projects in Jharkhand and Ranchi; combination of debt, internal accruals, and vendor finance.
Retail long-term target: 25-30% of group revenue
Management aspiration for retail to contribute 25-30% of total revenue within 3-5 years, up from current 8%, leveraging PPP infrastructure and preventive healthcare adoption.